CLINICAL_TRIALS
trial_result
· 2026-03-13
Clinical Trial Update: Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE [Phase 2]
Summary
Phase 2 clinical trial evaluating dasatinib monotherapy in AML patients refractory to venetoclax-azacitidine; recruitment is ongoing.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institut Paoli-Calmettes | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING